News

April 2010

9 April 2010
ANGIOBLAST’S MARKET EXCLUSIVITY FOR ITS BIOLOGIC PRODUCTS STRENGTHENED BY NEW UNITED STATES HEALTH CARE ACT

December 2009

18 December 2009
SINGLE DOSE OF PROPRIETARY ADULT STEM CELLS REGENERATES DAMAGED PANCREAS AND REDUCES BLOOD GUCOSE LEVELS IN DIABETES

November 2009

18 November 2009
SUSTAINED SIX-MONTH IMPORVEMENT IN HEART MUSCLE FUNCTION BY “OFF-THE-SHELF” ADULT STEM CELLS

06 November 2009
SUCCESSFUL BONE MARROW REGENERATION IN CANCER PATIENTS USING CORD BLOOD EXPANDED BY PROPRIETARY STEM CELLS

August 2009

25 August 2009
ANGIOBLAST CLOSES $10M EQUITY-BASED FINANCING

05 August 2009
PROPRIETARY TECHNOLOGY IN WORLD-FIRST ALLOGENEIC STEM CELL TRIAL FOR TREATMENT OF END-STAGE HEART FAILURE IN PATIENTS SUPPORTED BY MECHANICAL HEART ASSIST DEVICES

June 2009

2
4 June 2009
FIRST PATIENTS IN BONE MARROW TRANSPLANT TRIAL SHOW EARLIER ENGRAFTMENT. Potential for accelerated Phase 3 program

May 2009

14 May 2009
HEART MUSCLE FUNCTION IMPROVED SIGNIFICANTLY AFTER SINGLE, LOWEST-DOSE INJECTION OF “OFF-THE-SHELF” STEM CELLS IN PATIENTS WITH HEART FAILURE

February 2009

25 February 2009
FIRST GROUP OF HEART FAILURE PATIENTS TREATED WITH “OFF-THE-SHELF” ADULT STEM CELLS SUCCESSFULLY PASS KEY SAFETY MILESTONE

November 2008

14 November 2008
FROST & SULLIVAN SELECTS PROPRIETARY TECHNOLOGY PLATFORM AS U.S. STEM CELL MARKET INNOVATION OF THE YEAR

11 November 2008
PROPRIETARY STEM CELLS FOR HEART FAILURE HIGHLIGHTED AT MAJOR CARDIOLOGY CONFERENCE IN UNTED STATES

05 November 2008
Bone Marrow Transplant Trial Using Proprietary Cell Therapy Receives United States FDA Clearance and Institutional Ethics Approval

October 2008

13 October 2008
IRST HEART FAILURE PATIENTS SUCCESSFULLY IMPLANTED IN UNITED STATES - Angioblast technology being tested in first trial of allogeneic, or “off-the-shelf” adult stem cells for congestive heart failure

September 2008

25 September 2008
UBS LIFE SCIENCES INVESTOR CONFERENCE FEATURES ANGIOBLAST

17 September 2008
FDA GRANTS ORPHAN DRUG DESIGNATION FOR USE OF PROPRIETARY STEM CELLS IN BONE MARROW TRANSPLANTS

 

July 2008

10 July 2008
ALLOGENEIC STEM CELLS EFFECTIVELY TREAT EYE DISEASES

June 2008

05 June 2008
UNITED STATES FDA CLEARS PHASE 2 TRIAL FOR CONGESTIVE HEART FAILURE Major New Market Opportunity

April 2008

09 April 2008
U.S. HEART ATTACK TRIAL UPDATE -‘Most Exciting Stem Cell Therapy In Heart Research Today’

October 2007

30 October 2007
FORMER JOHNSON AND JOHNSON VICE CHAIRMAN JOINS ANGIOBLAST BOARD

September 2007

27 September 2007
ANGIOBLAST FEATURED AT UBS GLOBAL LIFE SCIENCES CONFERENCE IN NEW YORK

August 2007

10 August 2007
SUCCESSFUL CLINICAL OUTCOMES IN STEM CELL HEART TRIAL. Heart muscle recovery shown in all patients.

May 2007

02 May 2007
FDA Clearance Received For Heart Attack Stem Cell Clinical Trial

April 2007

02 April 2007
FDA submission filed for clinical trial of stem cells in heart attack patients

December 2006

01 December 2006
Heart function improves in stem cell trials

March 2006

08 March
Press Release covering Angioblast Human Clinical Trial

February 2006

28 February
Mesoblast announces that Mesoblast and Angioblast well ahead of schedule.

06 February
First two patients in heart attack clinical study safely implanted with adult stem cells.